As of Dec 05
| +0.04 / +1.23%|
The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate represents a +67.68% increase from the last price of 3.28.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.